Clarity Pharmaceuticals Ltd

ASX:CU6 Stock Report

Market Cap: AU$1.9b

Clarity Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:CU6 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Sep 24BuyAU$3,755,075Bank of America Corporation, Asset Management ArmCompany444,419AU$8.45
23 Sep 24SellAU$2,097,510Bank of America Corporation, Asset Management ArmCompany250,293AU$8.38
20 Sep 24BuyAU$47,678Merrill Lynch & Co. Inc., Banking InvestmentsCompany5,479AU$8.70
20 Sep 24SellAU$1,539,908Merrill Lynch & Co. Inc., Banking InvestmentsCompany185,399AU$8.31
17 Sep 24BuyAU$55,557,322Bank of America Corporation, Asset Management ArmCompany10,426,657AU$5.33
17 Sep 24SellAU$42,321,738Bank of America Corporation, Asset Management ArmCompany7,362,426AU$5.75
12 Sep 24BuyAU$2,522,932Merrill Lynch & Co. Inc., Banking InvestmentsCompany409,239AU$6.16
03 Sep 24SellAU$1,595,408Merrill Lynch & Co. Inc., Banking InvestmentsCompany221,711AU$7.20
20 May 24BuyAU$67,997Robert ThomasIndividual15,908AU$4.40
29 Apr 24BuyAU$86,935Robert ThomasIndividual34,092AU$2.55
29 Nov 23SellAU$387,963Charles MorganIndividual300,000AU$1.29

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CU6?
Owner TypeNumber of SharesOwnership Percentage
State or Government3,599,9201.12%
Private Companies35,448,46211.1%
Institutions40,064,43412.5%
Individual Insiders57,135,85817.8%
General Public183,962,79157.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.3%.


Top Shareholders

Top 25 shareholders own 42.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.66%
Christopher Roberts
18,111,280AU$108.1m1.12%no data
5.22%
TM Ventures Pty Ltd.
16,699,842AU$99.7m-11.1%no data
4.9%
Alan Taylor
15,693,438AU$93.7m7.42%no data
4.62%
The Vanguard Group, Inc.
14,802,513AU$88.4m0%no data
3.06%
Argo Investments Limited
9,802,322AU$58.5m6%0.79%
2.51%
Yarrawah Pty Ltd
8,040,000AU$48.0m3.03%no data
2.13%
Vantres Pty Ltd
6,812,340AU$40.7m-9.02%no data
2.06%
Charles Morgan
6,600,041AU$39.4m0%no data
1.89%
Matthew Harris
6,065,800AU$36.2m0%no data
1.56%
Smarter Capital Pty Ltd
5,004,543AU$29.9m0%no data
1.46%
Bank of America Corporation, Asset Management Arm
4,675,014AU$27.9m0%0.01%
1.35%
Colin Biggin
4,334,085AU$25.9m33.4%no data
1.22%
Kylaco Pty Ltd
3,896,280AU$23.3m0%no data
1.12%
Australian Nuclear Science and Technology Organisation
3,599,920AU$21.5m0%no data
1%
Guido Belgiorno-Nettis
3,210,425AU$19.2m3.03%no data
0.81%
BlackRock, Inc.
2,586,748AU$15.4m5.7%no data
0.36%
Robert Thomas
1,145,000AU$6.8m0%no data
0.34%
Michelle Parker
1,077,710AU$6.4m101%no data
0.22%
Thomas Ramdahl
720,000AU$4.3m38.5%no data
0.21%
BetaShares Capital Limited
675,421AU$4.0m2.36%0.01%
0.17%
Merrill Lynch & Co. Inc., Banking Investments
548,412AU$3.3m0%no data
0.16%
Charles Schwab Investment Management, Inc.
518,832AU$3.1m0%no data
0.12%
Portland Investment Counsel Inc.
400,235AU$2.4m0%0.49%
0.11%
Norges Bank Investment Management
367,730AU$2.2m0%no data
0.11%
SEI Investments Management Corporation
361,380AU$2.2m255%no data